Αssociated Press reports from Berlin that the EU drug agency said Tuesday it may need another four weeks to decide whether to grant its first approval for a coronavirus vaccine, even as authorities in the United States and Britain continued to aim for a green light before Christmas.
The European Medicines Agency plans to convene a meeting by December 29 to decide if there is enough safety and efficacy data about the vaccine developed by Pfizer and BioNTech for it to be approved, the regulator said. The agency also said it could decide as early as Jan. 12 whether to approve a rival shot by American pharmaceutical company Moderna Inc, which was submitted to U.S. and European regulators this week.
If its vaccine is approved, Germany-based BioNTech said its use in Europe could begin before the end of 2020 — but that seems quite ambitious, given that the EU Commission usually needs to rubber-stamp the regulator’s decision. Still, the regulator has also left open the possibility that the date of that meeting will be brought forward if data comes in faster.
The approval date now being eyed would be later than some European countries had hoped. Germany, which has given BioNTech 375 million euros ($450 million) in funding to develop the vaccine, has been preparing to start immunizing people from mid-December onward.
Read the full report at thenationalherald.com
RELATED TOPICS: Greece, Greek tourism news, Tourism in Greece, Greek islands, Hotels in Greece, Travel to Greece, Greek destinations, Greek travel market, Greek tourism statistics, Greek tourism report
Photo Source: pixabay.com
